Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Sy Mukherjee
Sy Mukherjee is a former health care reporter for
Fortune.
Page 34 of 100
Health
The Ideal Diet That Doesn’t Exist: Brainstorm Health
By
Sy Mukherjee
Health
Help Us Find the Companies Changing the World: Brainstorm Health
By
Sy Mukherjee
Health
The Ethics of ‘Biohacking’ and Digital Health Data: Brainstorm Health
By
Sy Mukherjee
Health
Digital Bike Maker Peloton’s Confidential-ish IPO: Brainstorm Health
By
Sy Mukherjee
Health
A Holdout on the CVS-Aetna Deal: Brainstorm Health
By
Sy Mukherjee
Health
The World’s Largest Cancer Conference: Brainstorm Health
By
Sy Mukherjee
Health
Grail Touts Its Blood Test for Detecting Cancer Early: Brainstorm Health
By
Sy Mukherjee
Health
From Pokemon Go to… Pokemon Sleep?—Brainstorm Health
By
Sy Mukherjee
Health
Brainstorm Health: Amarin Stock, Oklahoma Opioid Testimony, Work Burnout
By
Sy Mukherjee
Commentary
How This Biotech Wants to Become a Stem Cell Therapy Success Story
By
Sy Mukherjee
Health
Brainstorm Health: Athersys Stem Cell Treatment, Alexa in Medicine, Oklahoma Opioid Suit
By
Sy Mukherjee
Health
Brainstorm Health: Novartis $2.1 Million Drug, Brexit Fallout, Jakafi Drug Approval
By
Sy Mukherjee
Health
Brainstorm Health: Heart Disease, Amazon Emotion Detection, JPMorgan and Purdue
By
Sy Mukherjee
Health
Brainstorm Health: CRISPR V. Superbugs, Gottlieb to NEA, UniQure Gene Therapy
By
Sy Mukherjee
Health
Brainstorm Health: Verily Pharma Partners, ‘Conscience’ Clause Lawsuits, Merck’s Mulligan
By
Sy Mukherjee